Stay updated on Denosumab with Checkpoint Inhibitors in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Denosumab with Checkpoint Inhibitors in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Denosumab with Checkpoint Inhibitors in Melanoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-12T02:18:40.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the funding-lapse notice and Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T14:12:02.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding status and the NIH Clinical Center operations, and updated the page version to v3.4.1. The previous version note v3.4.0 was removed.
    Difference
    0.4%
    Check dated 2026-02-04T10:24:56.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Show glossary toggle is now displayed, and meta-text was updated to 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'.
    Difference
    0.2%
    Check dated 2026-01-28T05:53:24.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.4, replacing v3.3.3, with no changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:43:49.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a global Locations section with state-specific subsections (New South Wales, Queensland, Tasmania, Victoria, Western Australia) and a revision note (v3.3.3); removed the HHS Vulnerability Disclosure link and the prior region-specific location subsections (v3.3.2).
    Difference
    0.6%
    Check dated 2025-12-23T13:32:32.000Z thumbnail image

Stay in the know with updates to Denosumab with Checkpoint Inhibitors in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Denosumab with Checkpoint Inhibitors in Melanoma Clinical Trial page.